Viewing Study NCT00739661


Ignite Creation Date: 2025-12-24 @ 12:43 PM
Ignite Modification Date: 2026-04-21 @ 1:33 PM
Study NCT ID: NCT00739661
Status: COMPLETED
Last Update Posted: 2017-06-08
First Post: 2008-08-21
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission
Sponsor: Genentech, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: SHH4489g
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators